{"date": "2022-02-08 14:11:09.836000+00:00", "ticker": "AMZN", "mrkt_info": {"open": 3158.71, "close": 3223.79}, "html": "<div class=\"storyContent\" lang=\"en\"><style type=\"text/css\">.storyContent * {border-color:inherit !important;outline-color:inherit !important;}</style><div class=\"tr-npp-body\">\n<pre>ELSE NUTRITION HOLDINGS INC (\"BABY-T;BABYF-0\")\n- World Class Infant Nutrition Expert Dr. Bo Lonnerdal, joins Else's\n- Scientific Advisory Board\n\n     ELSE NUTRITION HOLDINGS INC (\"Else\" or the \"Company\") the Plant-Based\nbaby, toddler and children nutrition company, is pleased to announce that\nDr. Bo Lonnerdal has joined its Scientific Advisory Board.\n\n     Dr. Lonnerdal is the Distinguished Professor Emeritus of Nutrition &amp;\nInternal Medicine at University of California, Davis (UCD). He has an\nactive research program in pediatric nutrition at UCD. He has mentored many\nundergraduate and graduate students, as well as post-doctoral scholars and\nvisiting scientists from across the world. Dr. Lonnerdal received his\nmaster's and doctorate degrees in biochemistry from the University of\nUppsala in Sweden and has been professor at University of California Davis\nsince 1980. Dr. Lonnerdal's research program is focused on two main areas:\nInfant/Pediatric Nutrition and Trace Element Metabolism.\n\n     \"We are very pleased that Dr. Lonnerdal has joined our Advisory Board.\nHe's a world class expert in infant/pediatric nutrition, and his expertise\nwill greatly benefit the Company as we change the paradigm of infant\nnutrition,\" said Hamutal Yitzhak, Else Nutrition CEO &amp; Co-Founder.\n\n     About Else Nutrition Holdings Inc.\n\n     Else Nutrition GH Ltd. is an Israel-based food and nutrition company\nfocused on developing innovative, clean and plant-based food and nutrition\nproducts for infants, toddlers, children, and adults. Its revolutionary,\nplant-based, non-soy, formula is a clean-ingredient alternative to\ndairy-based formula. Else Nutrition (formerly INDI) won the \"2017 Best\nHealth and Diet Solutions\" award at the Global Food Innovation Summit in\nMilan. Else Plant-Based Complete Nutrition for Toddlers was recently ranked\nas the #1 Top seller in the baby and toddler formula category on Amazon.\nThe Company recently received the World Plant-Based Award for \"Best dairy\nalternative product\" in New York at World Plant-Based Expo in late 2021.\nThe holding company, Else Nutrition Holdings Inc., is a publicly traded\ncompany, listed as TSX Venture Exchange under the trading symbol BABY and\nis quoted on the US OTC Markets QX board under the trading symbol BABYF and\non the Frankfurt Exchange under the symbol 0YL. Else's Executives includes\nleaders hailing from leading infant nutrition companies. Many of Else\nadvisory board  members had past executive roles in companies such as Mead\nJohnson, Abbott Nutrition, Plum Organics and leading infant nutrition\nSocieties,  and some of them currently serve in different roles in leading\nmedical centers and academic institutes such as Boston Children's Hospital,\nPediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider\nChildren's Medical Center of Israel, Rambam Medical Center and Technion,\nIsrael and University Hospital Brussels, Belgium.\n     For more information, visit: elsenutrition.com or @elsenutrition on\nFacebook and Instagram.\n\nContact:\nLytham Partners, LLC\nMr. Ben Shamsian\nNew York | Phoenix\nE: shamsian@lythampartners.com\nP: 646-829-9701\n\n     TSX Venture Exchange\n\n     Neither the TSX Venture Exchange nor its regulation services provider\n(as that term is defined in the policies of the TSX Venture Exchange)\naccepts responsibility for the adequacy or accuracy of this release.\n\n     Caution Regarding Forward-Looking Statements\n\n     This press release contains statements that may constitute\n\"forward-looking statements\" within the meaning of applicable securities\nlegislation. Forward-looking statements are typically identified by words\nsuch as \"will\" or similar expressions. Forward-looking statements in this\npress release include statements with respect to the anticipated dates for\nfiling the Company's financial disclosure documents. Such forward-looking\nstatements reflect current estimates, beliefs and assumptions, which are\nbased on management's perception of current conditions and expected future\ndevelopments, as well as other factors management believes are appropriate\nin the circumstances. No assurance can be given that the foregoing will\nprove to be correct. Forward-looking statements made in this press release\nassume, among others, the expectation that there will be no interruptions\nor supply chain failures as a result of COVID 19 and that the\nmanufacturing, broker and supply logistic agreement with the Company do not\nterminate. Actual results may differ from the estimates, beliefs and\nassumptions expressed or implied in the forward-looking statements. Readers\nare cautioned not to place undue reliance on any forward-looking\nstatements, which reflect management's expectations only as of the date of\nthis press release. The Company disclaims any obligation to update or\nrevise any forward-looking statements, whether as a result of new\ninformation, future events or otherwise, except as required by law.\n\n<a href=\"https://www.elsenutrition.com\" data-type=\"url\" class=\"tr-link\" translate=\"no\">https://www.elsenutrition.com</a>\n                       ______________________________\n       _______________________________________________\n\n     ____________________________________________________________   \n      (c)2022 Market News Publishing Inc.  All rights reserved.    \n Toronto:(416)366-8881   Vancouver:(604)689-1101   Fax:(604)689-1106\n\n     2203800040.MNPRE2203801060-05382720220208</pre>\n</div><p class=\"line-break\"><br/></p><p class=\"tr-copyright\">Copyright (c) 2022 Thomson Reuters Limited.</p></div>"}